Evaluation of chlorofusin, its seven chromophore diastereomers, and key analogues

Tetrahedron Letters

Volumn 50, Issue 26, 2009, Pages 3151-3153

  Clark, Ryan C ^a   Lee, Sang Yeul ^a   Hwang, Inkyu ^a   Searcey, Mark ^b   Boger, Dale L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFUSIN; PROTEIN; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOPHORE; DIASTEREOISOMER; INHIBITION KINETICS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STEREOCHEMISTRY;

EID: 67349225763     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.01.081     Document Type: Article

References (29)

1. Levine A.J., Momand J., and Finlay C.A. Nature 351 (1991) 453
2. Vousden K.H. Cell 103 (2000) 691
3. Shen Y., and White E. Adv. Cancer Res. 82 (2001) 55
4. Chéne P. Nat. Rev. Cancer 3 (2003) 102
5. Zhang R., and Wang H. Curr. Pharm. Des. 6 (2000) 393
6. Momand J., Zambetti G.P., Olson D.C., George D., and Levine A.J. Cell 69 (1992) 1237
7. Chen J., Marechal V., and Levine A.J. Mol. Cell. Biol. 13 (1993) 4107
8. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., and Vogelstein B. Nature 362 (1993) 857
9. Haupt Y., Maya R., Kazaz A., and Oren M. Nature 387 (1997) 296
10. Kubbutat M.H.G., Jones S.N., and Vousden K.H. Nature 387 (1997) 299
11. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., and Pavletich N.P. Science 274 (1996) 948
12. Bullock A.N., and Fersht A.R. Nat. Rev. Cancer 1 (2001) 68
13. Fischer P.M., and Lane D.P. Trends Pharmacol. Sci. 25 (2004) 343
14. Duncan S.J., Grueschow S., Williams D.H., McNicholas C., Purewal R., Hajek M., Gerlitz M., Martin S., Wrigley S.K., and Moore M. J. Am. Chem. Soc. 123 (2001) 554
15. Correction:. J. Am. Chem. Soc. 124 (2002) 14503
16. Duncan S.J., Cooper M.A., and Williams D.H. Chem. Commun. (2003) 316
17. Clark, R.C.; Lee, S.Y.; Searcey, M.; Boger, D.L. Nat. Prod. Rep. 2009, 26, in press.
18. Boger D.L., Desharnais J., and Capps K. Angew. Chem., Int. Ed. 42 (2003) 4138
19. Desai P., Pfeiffer S.S., and Boger D.L. Org. Lett. 5 (2003) 5047
20. Lee S.Y., and Boger D.L. Tetrahedron 49 (2008) 6585
21. Malkinson J.P., Zloh M., Kadom M., Errington R., Smith P.J., and Searcey M. Org. Lett. 5 (2003) 5051
22. Mori T., Miyagi M., Suzuki K., Shibasaki M., Saikawa Y., and Nakata M. Heterocycles 72 (2007) 275
23. Lee S.Y., Clark R.C., and Boger D.L. J. Am. Chem. Soc. 129 (2007) 9860
24. Clark R.C., Lee S.Y., and Boger D.L. J. Am. Chem. Soc. 130 (2008) 12355
25. Qian W.-J., Wei W.-G., Zhang Y.-X., and Yao Z.-J. J. Am. Chem. Soc. 129 (2007) 6400
26. Woon E.C.Y., Arcieri M., Wilderspin A.F., Malkinson J.P., and Searcey M. J. Org. Chem. 72 (2007) 5146
27. McGovern S.L., Helfand B.T., Feng B., and Shoichet B.K. J. Med. Chem. 46 (2003) 4265
28. Seidler J., McGovern S.L., Doman T.N., and Shoichet B.K. J. Med. Chem. 46 (2003) 4477
29. 50 values for the analogues were determined. The assay was performed in triplicate using blank, which does not contain SGSG-p53 peptide as a negative control.